Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (321-330 of 548) with videos related to

Pageof 55
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid TumorsMartin Gutierrez, Victor Moreno, Kimberley M Heinhuis, et al.
BMJ Open|November 23, 2019
Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial resultsJessica Alonso-Molero, Antonio J Molina, Jose Juan Jiménez-Moleón, et al.
Cancer Treatment and Research Communications|July 30, 2021
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancerEmiliano Calvo, Alexander Spira, María de Miguel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 31, 2021
Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registryJorge Calderón-Parra, Valentín Cuervas-Mons, Victor Moreno-Torres, et al.
BMC Cancer|March 14, 2018
Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain projectTrinidad Dierssen-Sotos, Camilo Palazuelos-Calderón, José-Juan Jiménez-Moleón, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2025
A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancerByoung Chul Cho, Melissa Johnson, Jair Bar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2019
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized CohortNeal E Ready, Patrick A Ott, Matthew D Hellmann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 14, 2021
Transcriptome-wide <i>In Vitro</i> Effects of Aspirin on Patient-derived Normal Colon OrganoidsMatthew A M Devall, David A Drew, Christopher H Dampier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin LymphomaAntoine Hollebecque, Stefania Salvagni, Ruth Plummer, et al.
Cancer|June 23, 2022
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignanciesAntoine Hollebecque, Stefania Salvagni, Ruth Plummer, et al.
Pageof 55

Showing results (321-330 of 548) with videos related to

Sort By:
Pageof 55
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid TumorsMartin Gutierrez, Victor Moreno, Kimberley M Heinhuis, et al.
BMJ Open|November 23, 2019
Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial resultsJessica Alonso-Molero, Antonio J Molina, Jose Juan Jiménez-Moleón, et al.
Cancer Treatment and Research Communications|July 30, 2021
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancerEmiliano Calvo, Alexander Spira, María de Miguel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 31, 2021
Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registryJorge Calderón-Parra, Valentín Cuervas-Mons, Victor Moreno-Torres, et al.
BMC Cancer|March 14, 2018
Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain projectTrinidad Dierssen-Sotos, Camilo Palazuelos-Calderón, José-Juan Jiménez-Moleón, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2025
A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancerByoung Chul Cho, Melissa Johnson, Jair Bar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2019
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized CohortNeal E Ready, Patrick A Ott, Matthew D Hellmann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 14, 2021
Transcriptome-wide <i>In Vitro</i> Effects of Aspirin on Patient-derived Normal Colon OrganoidsMatthew A M Devall, David A Drew, Christopher H Dampier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin LymphomaAntoine Hollebecque, Stefania Salvagni, Ruth Plummer, et al.
Cancer|June 23, 2022
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignanciesAntoine Hollebecque, Stefania Salvagni, Ruth Plummer, et al.
Pageof 55